Literature DB >> 20579752

Serum levels of soluble receptor for advanced glycation end products (sRAGE) in Takayasu's arteritis.

Nitin Mahajan, Veena Dhawan, Sonal Malik, Sanjay Jain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20579752     DOI： 10.1016/j.ijcard.2010.05.075

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  8 in total

1.  F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics.

Authors:  Sampath Santhosh; Bhagwant Rai Mittal; Shankaramurthy Gayana; Anish Bhattacharya; Aman Sharma; Sanjay Jain
Journal:  J Nucl Cardiol       Date:  2014-05-30       Impact factor: 5.952

Review 2.  Biomarkers in vasculitis.

Authors:  Paul A Monach
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

3.  Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity.

Authors:  Debra A Cockayne; Donavan T Cheng; Benjamin Waschki; Sriram Sridhar; Palanikumar Ravindran; Holly Hilton; Galina Kourteva; Hans Bitter; Sreekumar G Pillai; Sudha Visvanathan; Kai-Christian Müller; Olaf Holz; Helgo Magnussen; Henrik Watz; Jay S Fine
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

4.  The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.

Authors:  Der-Yuan Chen; Yi-Ming Chen; Chi-Chen Lin; Chia-Wei Hsieh; Yen-Ching Wu; Wei-Ting Hung; Hsin-Hua Chen; Joung-Liang Lan
Journal:  BMC Musculoskelet Disord       Date:  2015-05-09       Impact factor: 2.362

Review 5.  Acknowledged signatures of matrix metalloproteinases in Takayasu's arteritis.

Authors:  Gang Wu; Nitin Mahajan; Veena Dhawan
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

6.  Plasma apolipopotein C-2 elevation is associated with Takayasu arteritis.

Authors:  Natsuko Tamura; Yasuhiro Maejima; Yuka Shiheido-Watanabe; Shun Nakagama; Mitsuaki Isobe; Tetsuo Sasano
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

7.  Methylglyoxal: A Relevant Marker of Disease Activity in Patients with Rheumatoid Arthritis.

Authors:  Ines Knani; Hassan Bouzidi; Saoussen Zrour; Naceur Bergaoui; Mohamed Hammami; Mohsen Kerkeni
Journal:  Dis Markers       Date:  2018-02-11       Impact factor: 3.434

8.  Incidence of primary graft dysfunction is higher according to the new ISHLT 2016 guidelines and correlates with clinical and molecular risk factors.

Authors:  Daoud Daoud; Lourdes Chacon Alberty; Qi Wei; Camila Hochman Mendez; Muhammad Hassan Masood Virk; Jonathan Mase; Peter Jindra; Matthew Cusick; Hyewon Choi; Natalie Debolske; Luiz C Sampaio; Doris A Taylor; Gabriel Loor
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.